An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition Mar 24, 2022 | 2018, Archives of Toxicology, Publication - legacy work ‹ Previous Combining In Vivo Data with In Silico Predictions for Modeling Hepatic Steatosis by Using Stratified Bagging and Conformal Prediction Next › ASPIS Cluster solidarity with Ukraine
